Biohaven (BHVN) Enterprise Value (2022 - 2026)

Biohaven has reported Enterprise Value for 6 years, with the latest figure at -$347.8 million in Q1 2026.

• Quarterly Enterprise Value fell 7.77% year-over-year to -$347.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$347.8 million (down 7.77% YoY) and the FY2025 annual result came in at -$319.1 million, up 34.33% from the prior year.
• Enterprise Value fell to -$347.8 million in Q1 2026 per BHVN's latest filing, from -$319.1 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$23.2 million in Q2 2022 and troughed at -$486.0 million in Q4 2024.
• A 5-year average of -$275.7 million and a median of -$319.1 million in 2025 frame the typical range for Enterprise Value.
• The widest YoY moves for Enterprise Value: up 85.99% in 2022, down 2798.06% in 2022.
• Over 5 years, Enterprise Value stood at -$465.3 million in 2022, then increased by 17.95% to -$381.8 million in 2023, then slipped by 27.28% to -$486.0 million in 2024, then surged by 34.33% to -$319.1 million in 2025, then retreated by 8.99% to -$347.8 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$347.8 million, -$319.1 million, and -$260.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.